Isitofu esitsha sokugonya sikuthintela umhlaza wolusu onobungozi!!!!

Akukabikho unyango, kodwa uphando lubonakalise i-serum yokuthintela umhlaza wolusu, ngoko ke iye yavela iyeza elitsha lokugonya umhlaza, eliqulethe amachiza amabini e-immunomodulatory kunye neekhemikhali, kunye ne-100% yempumelelo ekunyangeni umhlaza wolusu onobungozi kwiimpuku.

"Olu unyango oludibeneyo luvelise impendulo epheleleyo yonyango kunyango lwe-melanoma," watsho omnye wabaphandi, uDale Boggs, we-Scripps Research Institute eCalifornia.

Ucacisile ukuba olu gonyo lusekelwe ekuqeqesheni umzimba ukulwa nezinto zangaphandle ezibangela esi sifo, kwaye likwaqeqesha amajoni omzimba ukuba abeke iliso kwithumba.

Ukufumana olu gonyo, abaphandi kwiScripps kunye neYunivesithi yaseTexas Southwestern Medical Centre bavavanye phantse i-100 yeekhompawundi, bekhangela enye enokuthi ibancede bonyuse ukusebenza kwechiza le-immunosuppressive lokuthintela umhlaza.

Bafumene ikhemikhali ebizwa ngokuba yi-diprovocim edityaniswe ne-immunity kubantu kunye neempuku.

Inyathelo elilandelayo ibikukuqala ukuvavanya ukuba le khompawundi inganceda njani na ukunyanga amathumba kwiimpuku.

Abaphandi basebenzise iqela leempuku ezinovakalelo oluphezulu kumhlaza wolusu. Iimpuku zohlulwa ngokwamaqela apho amayeza ahlukeneyo azanywayo, kwaye uvavanyo lwathatha iintsuku ezingama-54, kwaye izinga lokuphendula leqela elitsha lokugonya laliyi-100%.

Abaphandi bachaza ukuba olu gonyo lusebenza ngokuvuselela amajoni omzimba ukwenza iiseli ezikhethekileyo zokulwa neeseli ezimhlophe zegazi ezingena kwithumba.

"Eli linyathelo lokuqala kuphela kwindlela enomdla yonyango lomhlaza, kwaye njengoko iziphumo ziye zaboniswa kuphela kwiimpuku ezinethumba eliguqulwe ngokwemfuza, kuya kuthatha ixesha ukubona ukuba olu hlobo lwesitofu somhlaza luya kusebenza njani ebantwini, "Utshilo uBoggs.